Swedish private equity giant EQT has made a takeover bid for Australia’s AUB Group, valuing the insurance brokerage firm at approximately A$5.25 billion (US$3.41 billion). Under the proposal, EQT is offering A$45 per AUB share, representing a 25.1% premium to the company’s last closing price. Following the announcement, AUB’s stock surged as much as 11% to a record high of A$39.95, though it remained below the offer price.
The bid comes after EQT’s earlier A$43 per share offer, indicating its strong interest in expanding within Australia’s financial services sector. AUB confirmed it had entered a confidentiality and exclusivity agreement with EQT, granting the firm six weeks of due diligence access beginning October 8.
Despite steady institutional backing, AUB’s shares have underperformed the broader market and its rival Steadfast Group over the past year. The company temporarily paused trading on Monday after its shares jumped more than 12%, citing the need to address speculation surrounding the potential acquisition.
AUB’s shareholder structure has evolved recently, notably after Odyssey Investment Partners sold down nearly A$277 million worth of shares last year. Its top investors now include First Sentier Investors and Capital World Investors, according to data from LSEG.
The takeover interest highlights growing M&A activity in Australia’s insurance sector, as global investors pursue stable returns in a resilient market. Analysts from Jarden noted that with organic growth slowing and brokers well-capitalized, consolidation is likely to continue.
EQT, known for its global acquisitions, has also been linked to potential bids for Perpetual’s wealth and corporate trust business, signaling its ongoing appetite for Australian financial assets.


SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
Brazil Meat Exports Weather Iran War Disruptions With Rerouted Shipments
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth
Apple Turns 50: From Garage Startup to AI Crossroads
Chinese Universities with PLA Ties Found Purchasing Restricted U.S. AI Chips Through Super Micro Servers
Bank of America's $72.5M Epstein Settlement: What You Need to Know
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
Cybersecurity Stocks Tumble After Anthropic's Claude Mythos AI Leak Sparks Market Fears
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026 



